Cargando…
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis
Arterial (AT) and venous (VT) thrombotic events are the most common complications in patients with polycythemia vera (PV) and are the leading causes of morbidity and mortality. In this regard, the impact of JAK2V617F variant allele frequency (VAF) is still debated. The purpose of the current study w...
Autores principales: | Guglielmelli, Paola, Loscocco, Giuseppe G., Mannarelli, Carmela, Rossi, Elena, Mannelli, Francesco, Ramundo, Francesco, Coltro, Giacomo, Betti, Silvia, Maccari, Chiara, Ceglie, Sara, Chiusolo, Patrizia, Paoli, Chiara, Barbui, Tiziano, Tefferi, Ayalew, De Stefano, Valerio, Vannucchi, Alessandro M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665926/ https://www.ncbi.nlm.nih.gov/pubmed/34897288 http://dx.doi.org/10.1038/s41408-021-00581-6 |
Ejemplares similares
-
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
por: Guglielmelli, Paola, et al.
Publicado: (2022) -
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera
por: Carobbio, Alessandra, et al.
Publicado: (2022) -
Polycythemia vera treatment algorithm 2018
por: Tefferi, Ayalew, et al.
Publicado: (2018) -
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients
por: Loscocco, Giuseppe G., et al.
Publicado: (2021) -
Polycythemia vera: historical oversights, diagnostic details, and therapeutic views
por: Tefferi, Ayalew, et al.
Publicado: (2021)